A Swedish study over the period 2000-2001 reported a 4-fold increase in TB risk for RA patients treated with TNF antagonists [48], whereas a Korean study observed a relative risk of TB of 8.9 for RA patients and 30.1 for RA patients treated with infliximab in comparison with the general population [49]. The gene discussed is TNF; the disease is tuberculosis.